Cite

HARVARD Citation

    Rosenblatt, L. et al. (2016). Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens. Open forum infectious diseases. p. . [Online]. 
  
Back to record